- Home
- PVH vs MRUS Comparison
PVH vs MRUS Comparison
Compare PVH & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVH
- MRUS
- Stock Information
- Founded
- PVH 1881
- MRUS 2003
- Country
- PVH United States
- MRUS Netherlands
- Employees
- PVH 28000
- MRUS N/A
- Industry
- PVH Apparel
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- PVH Consumer Discretionary
- MRUS Health Care
- Exchange
- PVH Nasdaq
- MRUS Nasdaq
- Market Cap
- PVH 3.4B
- MRUS 4.1B
- IPO Year
- PVH N/A
- MRUS 2016
- Fundamental
- Price
- PVH $71.32
- MRUS $65.56
- Analyst Decision
- PVH Buy
- MRUS Strong Buy
- Analyst Count
- PVH 15
- MRUS 13
- Target Price
- PVH $92.40
- MRUS $88.54
- AVG Volume (30 Days)
- PVH 1.1M
- MRUS 712.4K
- Earning Date
- PVH 08-26-2025
- MRUS 08-12-2025
- Dividend Yield
- PVH 0.20%
- MRUS N/A
- EPS Growth
- PVH N/A
- MRUS N/A
- EPS
- PVH 7.34
- MRUS N/A
- Revenue
- PVH $8,684,600,000.00
- MRUS $54,732,000.00
- Revenue This Year
- PVH $2.94
- MRUS $67.27
- Revenue Next Year
- PVH $2.01
- MRUS $0.49
- P/E Ratio
- PVH $9.73
- MRUS N/A
- Revenue Growth
- PVH N/A
- MRUS 42.77
- 52 Week Low
- PVH $59.28
- MRUS $33.19
- 52 Week High
- PVH $113.47
- MRUS $67.59
- Technical
- Relative Strength Index (RSI)
- PVH 44.57
- MRUS 69.61
- Support Level
- PVH $75.26
- MRUS $64.61
- Resistance Level
- PVH $77.66
- MRUS $67.59
- Average True Range (ATR)
- PVH 2.04
- MRUS 2.32
- MACD
- PVH -0.22
- MRUS 0.30
- Stochastic Oscillator
- PVH 18.07
- MRUS 84.96
About PVH PVH Corp.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, about 1,400 stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.